NYSE:MNK
Delisted
Mallinckrodt plc Stock News
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Stocks To Watch: Vaccine Players, Earnings Blitz And Fiscal Debate
08:24am, Saturday, 18'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
FDA Advisory Committee Recommends Mallinckrodt's Trelipressin
02:35pm, Thursday, 16'th Jul 2020
The Cardiovascular and Renal Drugs Advisory Committee of the FDA votes in favor of Mallinckrodt's (MNK) investigational agent, terlipressin, to treat adults with hepatorenal syndrome type 1.
The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO
12:31pm, Thursday, 16'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) * Atossa Therapeutics Inc (NASDAQ: ATOS) (announced r
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to rec
Stocks To Watch: Bank Earnings And SPAC Deals Blaze In
08:25am, Saturday, 11'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Mallinckrodt to Report Earnings Results for Second Quarter 2020
10:45am, Thursday, 09'th Jul 2020
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will report second quarter 2020 earnings results for the period ended June 26, 2020 on Tuesday, Aug. 4, 2020.
FDA Advisory Committee to Review Mallinckrodt'sTerlipressin
01:54pm, Wednesday, 08'th Jul 2020
Mallinckrodt (MNK) announces that the Cardiovascular and Renal Drugs Advisory Committee of the FDA will hold a virtual meeting to review data on terlipressin.
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that the Cardiovascular and Renal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will, as exp
Hedge Funds Never Been Less Bullish On Mallinckrodt Public Limited Company (MNK)
10:56pm, Tuesday, 23'rd Jun 2020
In this article you are going to find out whether hedge funds think Mallinckrodt Public Limited Company (NYSE:MNK) is a good investment right now. We like to check what the smart money thinks first be
Beyond Air: COVID-19 And More
09:21am, Tuesday, 23'rd Jun 2020
A presentation in March caused XAIR to sell off, many snapped up the buying opportunity but the name is still below early-March highs. Updates provided on the d
Opioid Actions in New York State Bode Ill for Mallinckrodt, Says Citi
03:48pm, Wednesday, 17'th Jun 2020
“Opioid risk is coming back,” says analyst Navann Ty, who lowered her rating on the drugmaker to Sell in the face of a lawsuit and a separate investigation by the state.
Mallinckrodt to Present at the BMO Prescriptions for Success Healthcare Conference
10:45am, Wednesday, 17'th Jun 2020
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, will present on Tuesday, June 23, 2020 at the BMO Prescriptions for Success Healthcare Conference. Mark Trudeau, President and Chief E
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced its disappointment with the U.S. Court of Appeals for the District of Columbia decision to deny its request for a temporary
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced it will present data from the pivotal Phase 3 clinical trial (STRATA2016) of its investigational product StrataGraft®
Edited Transcript of MNK earnings conference call or presentation 5-May-20 12:30pm GMT
01:40am, Saturday, 13'th Jun 2020
Q1 2020 Mallinckrodt Plc Earnings Call
